|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-29 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 770M 673M 621M 574M 1.09B 73.4B 1.11B 7.43B 2.91B 36.12B 2.89B 2.83B 125B | P/E 2026 * |
-8.49x | P/E 2027 * | -6.92x |
|---|---|---|---|---|---|
| Enterprise Value | 634M 555M 511M 473M 898M 60.46B 913M 6.12B 2.4B 29.75B 2.38B 2.33B 103B | EV / Sales 2026 * |
111x | EV / Sales 2027 * | 120x |
| Free-Float |
97.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACLS THER
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 2024-01-16 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 2022-12-31 |
Hugh Davis
PSD | President | 67 | 2024-11-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 2022-12-31 |
Anand Mehra
BRD | Director/Board Member | 50 | 2014-08-31 |
| Director/Board Member | 59 | 2016-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.38% | +0.40% | +71.69% | +128.83% | 56.71B | |
| +4.91% | -3.30% | +71.97% | +92.14% | 51.3B | |
| +1.48% | +10.52% | +23.01% | +495.47% | 25.26B | |
| -0.59% | -1.00% | -16.73% | -12.99% | 23.65B | |
| +3.93% | +7.11% | +44.20% | -1.96% | 18.69B | |
| +2.01% | +7.22% | +41.55% | -24.93% | 17.71B | |
| -6.84% | +4.81% | +201.88% | +348.11% | 17.7B | |
| -0.92% | +8.90% | +38.48% | - | 14.26B | |
| +1.76% | +5.82% | +31.23% | +195.70% | 14.1B | |
| Average | +0.60% | +3.45% | +56.37% | +152.55% | 26.6B | |
| Weighted average by Cap. | +1.06% | +2.16% | +58.77% | +145.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.71M 5M 4.61M 4.26M 8.09M 545M 8.23M 55.13M 21.61M 268M 21.45M 20.98M 928M | 5.36M 4.69M 4.32M 4M 7.59M 511M 7.72M 51.71M 20.27M 251M 20.12M 19.68M 870M |
| Net income | -84.78M -74.16M -68.39M -63.22M -120M -8.09B -122M -818M -321M -3.98B -318M -311M -13.77B | -103M -89.67M -82.69M -76.44M -145M -9.78B -148M -989M -388M -4.81B -385M -377M -16.64B |
| Net Debt | -136M -119M -109M -101M -192M -12.93B -195M -1.31B -513M -6.36B -509M -498M -22.02B | -125M -109M -101M -93.13M -177M -11.91B -180M -1.21B -473M -5.86B -469M -459M -20.28B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
